We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+0.02%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.08B
AUM Growth
-$109M
Cap. Flow
-$88M
Cap. Flow %
-4.22%
Top 10 Hldgs %
17.5%
Holding
3,019
New
52
Increased
262
Reduced
623
Closed
69

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$2.94M
2
VZ icon
Verizon
VZ
+$2.82M
3
EHC icon
Encompass Health
EHC
+$2.04M
4
WBS icon
Webster Financial
WBS
+$1.98M
5
ABBV icon
AbbVie
ABBV
+$1.93M

Top Sells

Rank Stock Value
1
AMLP icon
Alerian MLP ETF
AMLP
+$16.3M
2
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$6.26M
3
IJK icon
iShares S&P Mid-Cap 400 Growth ETF
IJK
+$3.76M
4
SIVB
SVB Financial Group
SIVB
+$3.69M
5
AAPL icon
Apple
AAPL
+$3.61M

Sector Composition

Rank Sector Weight
1 Technology 14.51%
2 Financials 13.48%
3 Industrials 10.54%
4 Healthcare 9.4%
5 Consumer Discretionary 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FTR
1901
DELISTED
Frontier Communications Corp.
FTR
$51K ﹤0.01%
6,905
– –
AGX icon
1902
Argan
AGX
$7.84B
$50K ﹤0.01%
1,155
– –
ATRC icon
1903
AtriCure
ATRC
$2.22B
$50K ﹤0.01%
2,456
– –
BBSI icon
1904
Barrett Business Services
BBSI
$800M
$50K ﹤0.01%
2,424
– –
BFS
1905
Saul Centers
BFS
$850M
$50K ﹤0.01%
978
– –
CCS icon
1906
Century Communities
CCS
$2.04B
$50K ﹤0.01%
1,662
– –
DEM icon
1907
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.98B
$50K ﹤0.01%
1,055
-544
-34% -$26K
DXPE icon
1908
DXP Enterprises
DXPE
$3.04B
$50K ﹤0.01%
1,272
– –
HSTM icon
1909
HealthStream
HSTM
$849M
$50K ﹤0.01%
2,005
– –
IGLB icon
1910
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.8B
$50K ﹤0.01%
845
-30
-3% -$1.82K
PEBO icon
1911
Peoples Bancorp
PEBO
$1.48B
$50K ﹤0.01%
1,418
– –
SNEX icon
1912
StoneX
SNEX
$8.05B
$50K ﹤0.01%
5,979
– –
TWI icon
1913
Titan International
TWI
$438M
$50K ﹤0.01%
3,947
– –
UTL icon
1914
Unitil
UTL
$992M
$50K ﹤0.01%
1,083
– –
VIVO
1915
DELISTED
Meridian Bioscience Inc
VIVO
$50K ﹤0.01%
3,556
– –
VRS
1916
DELISTED
Verso Corporation
VRS
$50K ﹤0.01%
2,960
– –
SVU
1917
DELISTED
SUPERVALU Inc.
SVU
$50K ﹤0.01%
3,281
– –
XCRA
1918
DELISTED
Xcerra Corporation
XCRA
$50K ﹤0.01%
4,282
– –
AORT icon
1919
Artivion
AORT
$1.39B
$49K ﹤0.01%
2,420
– –
ATNI icon
1920
ATN International
ATNI
$478M
$49K ﹤0.01%
816
– –
CIVI
1921
DELISTED
Civitas Resources
CIVI
$49K ﹤0.01%
1,784
– –
DFIN icon
1922
Donnelley Financial Solutions
DFIN
$1.17B
$49K ﹤0.01%
2,855
– –
SWBI icon
1923
Smith & Wesson
SWBI
$636M
$49K ﹤0.01%
6,158
– –
VICR icon
1924
Vicor
VICR
$10.4B
$49K ﹤0.01%
1,707
– –
FINL
1925
DELISTED
Finish Line
FINL
$49K ﹤0.01%
3,610
– –
75 76
77
78 79

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return

Ameritas Investment Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Ameritas Investment Partners held 3,019 positions worth $2.08B, down 5% from $2.19B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Ameritas Investment Partners withdrew a net $88M in Q1 2018, closing 69 positions and reducing 623 holdings. Its most notable exit was Bioverativ Inc. Common Stock, an estimated $1.75M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.

Against the trend, Ameritas Investment Partners opened a new position in Encompass Health worth $2.16M.

  • Ameritas Investment Partners's largest Q1 2018 buy was Encompass Health: 47,494 shares worth $2.16M.
  • Ameritas Investment Partners added most to Visa in Q1 2018, an estimated $2.94M increase.
  • Ameritas Investment Partners's biggest Q1 2018 reduction was Alerian MLP ETF, cutting an estimated $16.3M.
  • Ameritas Investment Partners fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $1.75M.
  • Ameritas Investment Partners's ten largest holdings make up 18% of its $2.08B portfolio in Q1 2018.
  • Ameritas Investment Partners opened 52 new positions and closed 69 in Q1 2018.
  • Ameritas Investment Partners's portfolio value fell 5% quarter-over-quarter to $2.08B.

Based on Ameritas Investment Partners's 13F filing for Q1 2018, filed 15 May 2018.